Clinical Trial Update: EMaBS TB Vaccine Study [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for the EMaBS TB vaccine, reporting safety and immunogenicity data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• EMaBS TB vaccine

Snippet

Sponsor: University of Oxford | Conditions: Safety, Immunogenicity | Phase 1, Phase 2 | Status: COMPLETED